Literature DB >> 9520876

Internal fixation of multiple fractures in patients with polytrauma.

H Tscherne1, G Regel, H C Pape, T Pohlemann, C Krettek.   

Abstract

Within the last decade understanding of the pathogenetic consequences of trauma has been improved significantly. An additional reduction of lethality has been achieved that in part is related to increasing discrimination of complex injury patterns. Accordingly, additional staging in fracture management of these injuries has been developed. An overview of the current status of fracture management in polytrauma is given and certain regimens that are still controversially are discussed. The principles determined are based on the treatment experience of 4003 multiply injured patients within the past 23 years. The most important principles within the first hours after trauma represent adequate hemorrhage control. In fracture treatment the primary goal remains to perform primary stable osteosynthesis. In severe polytrauma with severe injuries to the extremities, the first decision is whether limb salvage can be achieved without risk of deterioration of the patient's condition. If this is the case, open fractures Grades III b and c usually can be stabilized primarily by unreamed intramedullary nailing or percutaneous plating. The priority pattern in multiple closed fractures is as follows: (1) tibia; (2) femur; (3) pelvis; (4) spine; and (5) upper extremity. Exceptions may ensue if severe head or thoracic trauma is present. Delayed treatment is performed for complex joint reconstruction, definitive treatment of maxillofacial injuries, and soft tissue reconstruction.

Entities:  

Mesh:

Year:  1998        PMID: 9520876

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  16 in total

Review 1.  [Operative strategies in the treatment of upper limb fractures in polytraumatized patients].

Authors:  J Blum; E Gercek; M Hansen; P M Rommens
Journal:  Unfallchirurg       Date:  2005-10       Impact factor: 1.000

Review 2.  [Management of spine injuries in polytraumatized patients].

Authors:  C E Heyde; W Ertel; R Kayser
Journal:  Orthopade       Date:  2005-09       Impact factor: 1.087

3.  In-hospital mortality from femoral shaft fracture depends on the initial delay to fracture fixation and Injury Severity Score: a retrospective cohort study from the NTDB 2002-2006.

Authors:  Robert Victor Cantu; Sara Catherine Graves; Kevin F Spratt
Journal:  J Trauma Acute Care Surg       Date:  2014-06       Impact factor: 3.313

4.  Standalone percutaneous transiliac plating of vertically unstable sacral fractures: outcomes, complications, and recommendations.

Authors:  Mostafa A Ayoub; Hossam M Gad; Osama A Seleem
Journal:  Eur Spine J       Date:  2015-04-22       Impact factor: 3.134

5.  Displaced spinopelvic dissociation with sacral cauda equina syndrome: outcome of surgical decompression with a preliminary management algorithm.

Authors:  Mostafa A Ayoub
Journal:  Eur Spine J       Date:  2012-06-26       Impact factor: 3.134

Review 6.  Immune depression in musculoskeletal trauma.

Authors:  Olav Reikerås
Journal:  Inflamm Res       Date:  2010-02-11       Impact factor: 4.575

Review 7.  [Developments in polytrauma management. Priority-based strategy].

Authors:  N P Haas; T Lindner; H J Bail
Journal:  Chirurg       Date:  2007-10       Impact factor: 0.955

Review 8.  [Decision making and and priorities for surgical treatment during and after shock trauma room treatment].

Authors:  H C Pape; F Hildebrand; C Krettek
Journal:  Unfallchirurg       Date:  2004-10       Impact factor: 1.000

9.  Vertically unstable sacral fractures with neurological insult: outcomes of surgical decompression and reconstruction plate internal fixation.

Authors:  Mostafa A Ayoub
Journal:  Int Orthop       Date:  2007-10-27       Impact factor: 3.075

10.  Trauma care in Germany: an inclusive system.

Authors:  Johannes A Sturm; Hans-Christoph Pape; Thomas Dienstknecht
Journal:  Clin Orthop Relat Res       Date:  2013-09       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.